SCHEMBL158178

SCHEMBL158178

NC(=O)c1ncccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27431959 0.97 P2RX7 (0.52)
Bromide SCHEMBL10718877 0.97 P2RX7 (0.52)
Hydrochloric Acid SCHEMBL25337662 0.97 P2RX7 (0.52)
Ammonia Solution, Strong SCHEMBL17104818 0.97 P2RX7 (0.52)
Hydrochloric Acid SCHEMBL27440453 0.97 P2RX7 (0.52)
Pyridine SCHEMBL1880098 0.88 P2RX7 (0.45)
Thiophene SCHEMBL357409 0.86 P2RX7 (0.43)
SCHEMBL28417574 0.86 P2RX7 (0.43)
Pyrrole SCHEMBL985895 0.86 P2RX7 (0.48)
Trifluoroacetic Acid SCHEMBL3996079 0.84 L3MBTL1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1765 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734976-A2 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS RyCarma Therapeutics, Inc. (US) 2026-05-06 EP claimed
EP-4688157-A1 3H-PYRAZOLO[4.3:f] QUINOLINE-BASED COMPOUNDS AS STING ANTAGONISTS Purdue Research Foundation (US) 2026-02-11 EP claimed
EP-4301736-B1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2025-10-08 EP claimed
US-20250230154-A1 COMPOUND HAVING SHP2 PROTEIN DEGRADING ACTIVITY, AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2025-07-17 US claimed
CN-119841853-A Crystal form of pyrimidine carboxamide compound and preparation method thereof 上海泓博尚奕药物技术有限公司 2025-04-18 CN claimed
WO-2025072451-A1 RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES VIVIDION THERAPEUTICS, INC. (US) 2025-04-03 WO claimed
CN-119403798-A Novel compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof 东亚ST 株式会社 2025-02-07 CN claimed
WO-2025006617-A2 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2025-01-02 WO claimed
US-20240383863-A1 PREPARATION METHOD FOR PYRIMIDINE-2-AMINE INSTITUTE FOR BASIC SCIENCE (KR) 2024-11-21 US claimed
CN-113382990-B Substituted pyrrolidinamide III 格吕伦塔尔有限公司 2024-11-19 CN claimed
CN-1407985-A Heterocyclic dihydropyrimidines as potassium channel inhibitors BRISTOL MYERS SQUIBB CO (US) 2003-04-02 CN claimed
CN-1403446-A Catalytic synthesis process of methyl substituted pyrimidyl urea derivative DALIAN CHEMICAL PHYSICS INST (CN) 2003-03-19 CN claimed
WO-2002098989-A1 DYE MIXTURES OF FIBER-REACTIVE AZODYES AND THE USE THEREOF DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) 2002-12-12 WO claimed
EP-0977600-A2 CONTRAST AGENTS NYCOMED IMAGING A/S (NO) 2000-02-09 EP claimed
WO-1998047541-B1 CONTRAST AGENTS 1998-11-26 WO claimed
WO-1998047541-A1 CONTRAST AGENTS NYCOMED IMAGING AS (NO) 1998-10-29 WO claimed
EP-0341081-B1 Novel amino acid derivatives ONO PHARMACEUTICAL CO (JP) 1995-07-05 EP claimed
EP-0564499-B1 NOVEL AMINES, PROCESS FOR PRODUCING THEM AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER MANNHEIM GMBH (DE) 1995-04-12 EP claimed
CN-1014990-B Process for the preparation of 5-pyrimidinecarboxamides derivatives UNIROYAL CHEM CO INC (US) 1991-12-04 CN claimed
CN-86102767-A The preparation method of 5-pyrimidine carboxamide analog derivative 1987-01-07 CN claimed